Surgical Versus Medical Treatment of Acromegaly

Surgical Versus Medical Treatment of Acromegaly: Effects on Biochemical Markers

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01000090

Enrollment

Registered

2009-10-22

Start date

2009-10-31

Completion date

2011-06-30

Last updated

2015-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acromegaly

Keywords

Acromegaly, Somatostatin analogues, Treatment

Brief summary

Evaluate biochemical differences in acromegalic patients treated with surgery versus somatostatin analogues (SMS) (after surgery or alone). Hypothesis: Treatment modality exhibit different biochemical responses in acromegaly.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Acromegaly diagnosis * treated with Somatostatin analogues or surgery * in treatment control

Exclusion criteria

* treatment with GH-antagonist * never treated * not in treatment control

Countries

Denmark

Outcome results